MDGL logo

Madrigal Pharmaceuticals, Inc. (MDGL) Cash From Investing

Annual CFI:

-$274.39M+$228.13M(+45.40%)
December 31, 2024

Summary

  • As of today, MDGL annual cash from investing is -$274.39 million, with the most recent change of +$228.13 million (+45.40%) on December 31, 2024.
  • During the last 3 years, MDGL annual cash from investing has fallen by -$269.33 million (-5328.01%).
  • MDGL annual cash from investing is now -232.76% below its all-time high of $206.69 million, reached on December 31, 2022.

Performance

MDGL Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

Quarterly CFI:

$47.86M-$116.02M(-70.80%)
June 30, 2025

Summary

  • As of today, MDGL quarterly cash from investing is $47.86 million, with the most recent change of -$116.02 million (-70.80%) on June 30, 2025.
  • Over the past year, MDGL quarterly cash from investing has increased by +$169.96 million (+139.20%).
  • MDGL quarterly cash from investing is now -70.80% below its all-time high of $163.88 million, reached on March 31, 2025.

Performance

MDGL Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

TTM CFI:

-$38.60M+$169.96M(+81.49%)
June 30, 2025

Summary

  • As of today, MDGL TTM cash from investing is -$38.60 million, with the most recent change of +$169.96 million (+81.49%) on June 30, 2025.
  • Over the past year, MDGL TTM cash from investing has increased by +$297.36 million (+88.51%).
  • MDGL TTM cash from investing is now -118.68% below its all-time high of $206.69 million, reached on December 31, 2022.

Performance

MDGL TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MDGL Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+45.4%+139.2%+88.5%
3Y3 Years-5328.0%+148.8%-129.5%
5Y5 Years-993.6%+147.1%-128.8%

MDGL Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-232.8%+45.4%-70.8%+113.2%-118.7%+93.4%
5Y5-Year-232.8%+45.4%-70.8%+113.2%-118.7%+93.4%
All-TimeAll-Time-232.8%+45.4%-70.8%+113.2%-118.7%+93.4%

MDGL Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$47.86M(-70.8%)
-$38.60M(+81.5%)
Mar 2025
-
$163.88M(+441.8%)
-$208.56M(+24.0%)
Dec 2024
-$274.39M(+45.4%)
-$47.95M(+76.3%)
-$274.39M(+53.4%)
Sep 2024
-
-$202.39M(-65.8%)
-$588.56M(-75.2%)
Jun 2024
-
-$122.10M(-224.5%)
-$335.97M(-54.4%)
Mar 2024
-
$98.05M(+127.1%)
-$217.60M(+56.7%)
Dec 2023
-$502.52M(-343.1%)
-$362.12M(-821.4%)
-$502.52M(-579.0%)
Sep 2023
-
$50.20M(+1445.1%)
-$74.01M(-25.3%)
Jun 2023
-
-$3.73M(+98.0%)
-$59.07M(-63.6%)
Mar 2023
-
-$186.86M(-381.5%)
-$36.10M(-117.5%)
Dec 2022
$206.69M(+4188.7%)
$66.39M(+1.9%)
$206.69M(+32.5%)
Sep 2022
-
$65.14M(+238.6%)
$155.94M(+19.1%)
Jun 2022
-
$19.24M(-65.6%)
$130.90M(+55.2%)
Mar 2022
-
$55.93M(+257.5%)
$84.33M(+1768.3%)
Dec 2021
-$5.05M(-103.2%)
$15.64M(-61.0%)
-$5.05M(+80.2%)
Sep 2021
-
$40.09M(+246.7%)
-$25.50M(-187.4%)
Jun 2021
-
-$27.32M(+18.3%)
$29.17M(-61.6%)
Mar 2021
-
-$33.46M(-597.5%)
$75.86M(-52.5%)
Dec 2020
$159.78M(+420.3%)
-$4.80M(-105.1%)
$159.78M(+19.2%)
Sep 2020
-
$94.75M(+389.3%)
$134.07M(+98.4%)
Jun 2020
-
$19.36M(-61.6%)
$67.58M(-20.2%)
Mar 2020
-
$50.46M(+265.4%)
$84.66M(+175.7%)
Dec 2019
$30.71M(+108.1%)
-$30.51M(-207.9%)
$30.71M(-64.4%)
Sep 2019
-
$28.27M(-22.4%)
$86.20M(+152.5%)
Jun 2019
-
$36.44M(+1143.8%)
-$164.09M(+41.7%)
Mar 2019
-
-$3.49M(-114.0%)
-$281.44M(+26.0%)
Dec 2018
-$380.08M(-1627.1%)
$24.99M(+111.3%)
-$380.08M(+4.7%)
Sep 2018
-
-$222.03M(-174.4%)
-$398.98M(-105.8%)
Jun 2018
-
-$80.91M(+20.8%)
-$193.84M(-70.7%)
Mar 2018
-
-$102.12M(-1778.3%)
-$113.57M(-416.1%)
Dec 2017
-$22.01M(-200.1%)
$6.08M(+136.0%)
-$22.01M(-22.2%)
Sep 2017
-
-$16.89M(-2509.9%)
-$18.01M(-267.0%)
Jun 2017
-
-$647.00K(+93.9%)
$10.79M(-5.7%)
Mar 2017
-
-$10.56M(-204.8%)
$11.43M(-48.0%)
Dec 2016
$21.99M(>+9900.0%)
$10.08M(-15.4%)
$21.99M(+84.6%)
Sep 2016
-
$11.91M(>+9900.0%)
$11.91M(-19.0%)
Jun 2016
-
$0.00(0.0%)
$14.70M(+276.8%)
Mar 2016
-
$0.00(0.0%)
-$8.32M(>-9900.0%)
Dec 2015
$0.00
$0.00(-100.0%)
$0.00(+100.0%)
DateAnnualQuarterlyTTM
Sep 2015
-
$14.70M(+163.9%)
-$930.00K(+98.2%)
Jun 2015
-
-$23.02M(-376.8%)
-$51.21M(-206.4%)
Mar 2015
-
$8.32M(+994.3%)
-$16.72M(-89.2%)
Dec 2014
-$8.84M(+64.2%)
-$930.00K(+97.4%)
-$8.84M(-11.8%)
Sep 2014
-
-$35.58M(-410.0%)
-$7.91M(-128.6%)
Jun 2014
-
$11.48M(-29.1%)
$27.68M(-20.5%)
Mar 2014
-
$16.20M(-13.0%)
$34.82M(+290.1%)
Dec 2013
-$24.65M(-147.9%)
-
-
Jun 2013
-
$18.62M(+150.9%)
-$18.32M(+44.9%)
Mar 2013
-
-$36.62M(-661.6%)
-$33.24M(-234.3%)
Dec 2012
-$9.94M(-206.6%)
$6.52M(+195.3%)
-$9.94M(-382.2%)
Sep 2012
-
-$6.84M(-285.0%)
$3.52M(-79.4%)
Jun 2012
-
$3.70M(+127.8%)
$17.07M(+2260.9%)
Mar 2012
-
-$13.32M(-166.6%)
-$790.00K(-108.5%)
Dec 2011
$9.33M(+147.1%)
$19.99M(+198.0%)
$9.33M(+183.8%)
Sep 2011
-
$6.71M(+147.4%)
-$11.14M(+64.2%)
Jun 2011
-
-$14.16M(-342.3%)
-$31.08M(-35.1%)
Mar 2011
-
-$3.20M(-567.1%)
-$23.00M(-16.2%)
Dec 2010
-$19.80M(-194.1%)
-$480.00K(+96.4%)
-$19.80M(-752.8%)
Sep 2010
-
-$13.24M(-117.5%)
-$2.32M(-110.3%)
Jun 2010
-
-$6.09M(>-9900.0%)
$22.59M(-48.1%)
Mar 2010
-
$0.00(-100.0%)
$43.52M(+106.7%)
Dec 2009
$21.05M(+188.9%)
$17.00M(+45.6%)
$21.05M(+215.6%)
Sep 2009
-
$11.68M(-21.3%)
-$18.20M(+40.0%)
Jun 2009
-
$14.84M(+166.1%)
-$30.32M(+33.7%)
Mar 2009
-
-$22.47M(-1.0%)
-$45.76M(-93.2%)
Dec 2008
-$23.69M(-319.6%)
-$22.25M(-4911.7%)
-$23.69M(-929.4%)
Sep 2008
-
-$444.00K(+25.5%)
-$2.30M(+8.6%)
Jun 2008
-
-$596.00K(-50.9%)
-$2.52M(-101.0%)
Mar 2008
-
-$395.00K(+54.4%)
-$1.25M(-111.6%)
Dec 2007
$10.79M(-54.3%)
-$866.00K(-31.2%)
$10.79M(-26.9%)
Sep 2007
-
-$660.00K(-198.7%)
$14.74M(-4.3%)
Jun 2007
-
$669.00K(-94.3%)
$15.40M(+4.5%)
Mar 2007
-
$11.64M(+276.4%)
$14.73M(+376.4%)
Dec 2006
$23.57M(-39.8%)
$3.09M(+240.8%)
$3.09M(+240.8%)
Dec 2005
$39.18M(+189.4%)
-
-
Mar 2005
-
-$2.20M
-$2.20M
Dec 2004
-$43.81M(-8.4%)
-
-
Dec 2003
-$40.40M
-
-

FAQ

  • What is Madrigal Pharmaceuticals, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. annual cash from investing year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

What is Madrigal Pharmaceuticals, Inc. annual cash from investing?

The current annual cash from investing of MDGL is -$274.39M

What is the all-time high annual cash from investing for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high annual cash from investing is $206.69M

What is Madrigal Pharmaceuticals, Inc. annual cash from investing year-on-year change?

Over the past year, MDGL annual cash from investing has changed by +$228.13M (+45.40%)

What is Madrigal Pharmaceuticals, Inc. quarterly cash from investing?

The current quarterly cash from investing of MDGL is $47.86M

What is the all-time high quarterly cash from investing for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high quarterly cash from investing is $163.88M

What is Madrigal Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?

Over the past year, MDGL quarterly cash from investing has changed by +$169.96M (+139.20%)

What is Madrigal Pharmaceuticals, Inc. TTM cash from investing?

The current TTM cash from investing of MDGL is -$38.60M

What is the all-time high TTM cash from investing for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high TTM cash from investing is $206.69M

What is Madrigal Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

Over the past year, MDGL TTM cash from investing has changed by +$297.36M (+88.51%)
On this page